HUMALOG 200U/ML KWIKPEN 1 S

About

Humalog 200 units/mL KwikPen contains a concentrated formulation of Insulin Lispro, a rapid-acting insulin analogue. This formulation provides 200 units of insulin per milliliter, twice the concentration of standard U-100 insulin. Insulin Lispro acts very quickly, typically within 15-30 minutes, with a peak effect around 1-2 hours and a duration of action of 3-5 hours. The concentrated form is particularly useful for patients requiring higher daily doses of insulin, as it allows for smaller injection volumes, potentially improving comfort and reducing the risk of injection site reactions. It is used to control post-meal blood glucose spikes and can also be used for basal insulin needs in some regimens. Humalog 200U/mL is administered subcutaneously, usually shortly before or after a meal, and requires careful dosing to avoid hypoglycemia due to its potency.

Uses

• Management of type 1 diabetes mellitus.
• Management of type 2 diabetes mellitus requiring insulin.
• To control postprandial blood glucose levels.
• For patients requiring higher daily doses of rapid-acting insulin.

Directions For Use

Inject subcutaneously into the abdomen, thigh, or upper arm 15 minutes before or immediately after a meal. Rotate injection sites.

Benefits

• Rapid onset of action for mealtime glucose control.
• Allows for smaller injection volumes for high-dose users.
• Convenient pre-filled pen for ease of use.
• Helps prevent post-meal hyperglycemia.
• Flexible dosing around meal times.
• Effective for achieving glycemic targets.

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy (fat changes at injection site)
• Weight gain
• Peripheral edema
• Allergic reactions (rash, itching)
• Generalized allergic reactions (rare, but serious)
• Blurred vision (temporary)
• Headache
• Dizziness
• Palpitations
• Sweating

Safety Measures

• Alcohol - Avoid excessive alcohol consumption, as it can significantly increase the risk of hypoglycemia when using insulin.
• Pregnancy - Insulin is generally considered the preferred treatment for diabetes during pregnancy. Close monitoring and dose adjustments are crucial.
• Breastfeeding - Insulin is safe to use during breastfeeding as it does not pass into breast milk in significant amounts.
• Liver - Use with caution in patients with hepatic impairment, as insulin requirements may change. Close glucose monitoring is essential.
• Kidney - Use with caution in patients with renal impairment, as insulin requirements may decrease. Close glucose monitoring is essential.
• Lung - Generally safe for use in patients with lung conditions. No specific contraindications related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.